Lifecome Biochemistry Co.,Ltd. (002868.SZ)
CNY 15.88
(-2.87%)
CNY 15.88
(-2.87%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.55 Billion CNY | 142.12% |
| 2022 | 640.56 Million CNY | 19.42% |
| 2021 | 536.37 Million CNY | 164.8% |
| 2020 | 202.55 Million CNY | -12.52% |
| 2019 | 231.55 Million CNY | 273.18% |
| 2018 | 62.04 Million CNY | 2.45% |
| 2017 | 60.56 Million CNY | -39.02% |
| 2016 | 99.31 Million CNY | -35.31% |
| 2015 | 153.53 Million CNY | -22.93% |
| 2014 | 199.21 Million CNY | -12.03% |
| 2013 | 226.45 Million CNY | 5.37% |
| 2012 | 214.91 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 1.44 Billion CNY | 0.27% |
| 2024 Q2 | 1.43 Billion CNY | -8.39% |
| 2024 Q1 | 1.56 Billion CNY | 1.2% |
| 2023 Q4 | 1.55 Billion CNY | 28.56% |
| 2023 Q1 | 587.68 Million CNY | -8.26% |
| 2023 FY | 1.55 Billion CNY | 142.12% |
| 2023 Q2 | 830.79 Million CNY | 41.37% |
| 2023 Q3 | 1.2 Billion CNY | 45.21% |
| 2022 Q3 | 613.11 Million CNY | 10.6% |
| 2022 Q2 | 554.32 Million CNY | 6.55% |
| 2022 FY | 640.56 Million CNY | 19.42% |
| 2022 Q1 | 520.25 Million CNY | -3.01% |
| 2022 Q4 | 640.56 Million CNY | 4.48% |
| 2021 Q2 | 244.26 Million CNY | 6.6% |
| 2021 Q4 | 536.37 Million CNY | 17.61% |
| 2021 FY | 536.37 Million CNY | 164.8% |
| 2021 Q1 | 229.14 Million CNY | 13.13% |
| 2021 Q3 | 456.05 Million CNY | 86.71% |
| 2020 FY | 202.55 Million CNY | -12.52% |
| 2020 Q4 | 202.55 Million CNY | 2.91% |
| 2020 Q3 | 196.82 Million CNY | 11.96% |
| 2020 Q2 | 175.8 Million CNY | -7.29% |
| 2020 Q1 | 189.62 Million CNY | -18.11% |
| 2019 Q3 | 147.76 Million CNY | 81.53% |
| 2019 FY | 231.55 Million CNY | 273.18% |
| 2019 Q2 | 81.39 Million CNY | 70.49% |
| 2019 Q1 | 47.74 Million CNY | -23.05% |
| 2019 Q4 | 231.55 Million CNY | 56.7% |
| 2018 Q1 | 47.68 Million CNY | -21.27% |
| 2018 Q3 | 49.29 Million CNY | -2.91% |
| 2018 FY | 62.04 Million CNY | 2.45% |
| 2018 Q4 | 62.04 Million CNY | 25.87% |
| 2018 Q2 | 50.77 Million CNY | 6.48% |
| 2017 Q2 | 52.41 Million CNY | -21.96% |
| 2017 Q4 | 60.56 Million CNY | 9.14% |
| 2017 Q1 | 67.16 Million CNY | -32.38% |
| 2017 FY | 60.56 Million CNY | -39.02% |
| 2017 Q3 | 55.49 Million CNY | 5.88% |
| 2016 Q4 | 99.31 Million CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 FY | 99.31 Million CNY | -35.31% |
| 2015 FY | 153.53 Million CNY | -22.93% |
| 2014 FY | 199.21 Million CNY | -12.03% |
| 2013 FY | 226.45 Million CNY | 5.37% |
| 2012 FY | 214.91 Million CNY | 0.0% |